This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2025 Jun;132(12):1200.

doi: 10.1038/s41416-025-03036-y.

Retraction Note: Overexpression of HMGA1 promotes anoikis resistance and constitutive Akt activation in pancreatic adenocarcinoma cells

S-S Liau¹, A Jazag², K Ito², E E Whang³

Affiliations

Affiliations

¹ Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA, 02115, USA. liauss@hotmail.com.
² Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA, 02115, USA.
³ Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA, 02115, USA. ewhang1@partners.org.

PMID: 40307441
PMCID: PMC12152181 (available on 2026-04-30)
DOI: 10.1038/s41416-025-03036-y

Retraction Note: Overexpression of HMGA1 promotes anoikis resistance and constitutive Akt activation in pancreatic adenocarcinoma cells

S-S Liau et al. Br J Cancer. 2025 Jun.

. 2025 Jun;132(12):1200.

doi: 10.1038/s41416-025-03036-y.

Authors

S-S Liau¹, A Jazag², K Ito², E E Whang³

Affiliations

¹ Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA, 02115, USA. liauss@hotmail.com.
² Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA, 02115, USA.
³ Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA, 02115, USA. ewhang1@partners.org.

PMID: 40307441
PMCID: PMC12152181 (available on 2026-04-30)
DOI: 10.1038/s41416-025-03036-y

No abstract available

PubMed Disclaimer

Retraction of

Overexpression of HMGA1 promotes anoikis resistance and constitutive Akt activation in pancreatic adenocarcinoma cells.
Liau SS, Jazag A, Ito K, Whang EE. Liau SS, et al. Br J Cancer. 2007 Mar 26;96(6):993-1000. doi: 10.1038/sj.bjc.6603654. Epub 2007 Mar 6. Br J Cancer. 2007. Retraction in: Br J Cancer. 2025 Jun;132(12):1200. doi: 10.1038/s41416-025-03036-y. PMID: 17342093 Free PMC article. Retracted.

Similar articles

Overexpression of HMGA1 promotes anoikis resistance and constitutive Akt activation in pancreatic adenocarcinoma cells.
Liau SS, Jazag A, Ito K, Whang EE. Liau SS, et al. Br J Cancer. 2007 Mar 26;96(6):993-1000. doi: 10.1038/sj.bjc.6603654. Epub 2007 Mar 6. Br J Cancer. 2007. Retraction in: Br J Cancer. 2025 Jun;132(12):1200. doi: 10.1038/s41416-025-03036-y. PMID: 17342093 Free PMC article. Retracted.
HMGA1 is a molecular determinant of chemoresistance to gemcitabine in pancreatic adenocarcinoma.
Liau SS, Whang E. Liau SS, et al. Clin Cancer Res. 2008 Mar 1;14(5):1470-7. doi: 10.1158/1078-0432.CCR-07-1450. Clin Cancer Res. 2008. PMID: 18316571 Free PMC article.
High mobility group AT-hook 1 (HMGA1) is an independent prognostic factor and novel therapeutic target in pancreatic adenocarcinoma.
Liau SS, Rocha F, Matros E, Redston M, Whang E. Liau SS, et al. Cancer. 2008 Jul 15;113(2):302-14. doi: 10.1002/cncr.23560. Cancer. 2008. PMID: 18473350 Free PMC article.
RETRACTED: HMGA1 is a determinant of cellular invasiveness and in vivo metastatic potential in pancreatic adenocarcinoma.
Liau SS, Jazag A, Whang EE. Liau SS, et al. Cancer Res. 2006 Dec 15;66(24):11613-22. doi: 10.1158/0008-5472.CAN-06-1460. Cancer Res. 2006. Retraction in: Cancer Res. 2025 May 15;85(10):1946. doi: 10.1158/0008-5472.CAN-25-0888. PMID: 17178855 Retracted.
Lentivirus-mediated RNA interference of HMGA1 promotes chemosensitivity to gemcitabine in pancreatic adenocarcinoma.
Liau SS, Ashley SW, Whang EE. Liau SS, et al. J Gastrointest Surg. 2006 Nov;10(9):1254-62; discussion 1263. doi: 10.1016/j.gassur.2006.06.011. J Gastrointest Surg. 2006. PMID: 17114012

See all similar articles

References

1. Liau S-S, Jazag A, Whang EE. HMGA1 is a determinant of cellular invasiveness and in vivo metastatic potential in pancreatic adenocarcinoma. Cancer Res. 2006;66(24):11613–22. 10.1158/0008-5472.CAN-06-146. - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- PubMed Central